Kelly Girskis | President
Kelly is a PhD student in the Program of Neuroscience at Harvard. Her thesis work in Dr. Christopher Walsh's lab focuses on how evolutionary changes in the human genome contribute to species-specific gene regulation and corticogenesis.
Soufiane Aboulhouda | President
Soufiane is a PhD Candidate in the Biological and Biomedical Sciences program at Harvard. His research in the lab of Dr. George Church at the Wyss Institute is focused on genome engineering and cell therapies.
Emily Cohen | Vice President
Senior Director of Programming
Emily is a postdoc in the Pathology Department at Beth Israel Deaconess Medical Center. In the laboratory of Dr. Alex Toker, she is investigating the mechanism of resistance to therapeutic inhibitors in breast cancer.
Director of the Life Science Innovation Program (LSIP)
Becca is a PhD student in the Biological and Biomedical Sciences program at Harvard. Her thesis work in the lab of Dr. Lee Rubin focuses on leveraging the regenerative potential of stem cells to develop novel treatments for muscle disorders.
Director of Harvard Biotech Incubator (HBI)
Jeff is a PhD student in the Biological and Biomedical Sciences Program at Harvard. His thesis work in Dr. Frank Slack’s lab focuses on developing CRISPR and TALEN gene editing techniques to target both coding and non-coding RNAs in human embryonic stem cells.
Director of Healthcare Innovation and Commercialization (HIC) Course
Hannah is a PhD student in the Harvard/MIT Speech Hearing Bioscience and Technology program. In 2016 she was accepted into Harvard's Therapeutics Graduate Program to further focus on pharmacology, toxicology and drug discovery. Her concentration in translational
science has brought her to the Holt/Géléoc Lab to explore the effectiveness of gene therapy as an approach to restore auditory functioning in models of human deafness.